» Articles » PMID: 3258351

The Lpr Gene Causes an Intrinsic T Cell Abnormality That is Required for Hyperproliferation

Overview
Journal J Exp Med
Date 1988 Mar 1
PMID 3258351
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The lpr gene induces marked lymphoproliferation characterized by the massive accumulation of T cells of an unusual phenotype and concomitant autoimmune disease. To clarify the mechanism of the lpr effect, bone marrow cells from B6-lpr/lpr (Ly-1.2) and B6-+/+ (Ly-1.1) mice were transferred into lethally irradiated B6-lpr/lpr mice. As has been previously reported, recipients of the B6-lpr/lpr bone marrow showed the typical lpr phenotype with marked lymphadenopathy, splenomegaly and increased levels of autoantibodies; while the recipients of B6-+/+ bone marrow had normal sized lymph nodes and spleen and no autoantibodies. A third group of mice received an equal mixture of bone marrow cells from the B6-lpr/lpr and B6-+/+ donors. These mice showed both lymphadenopathy and autoantibody production comparable to that of recipients of the B6-lpr/lpr marrow alone. Immunofluorocytometric analysis of the lymphoid populations in these mixed bone marrow recipients established that the T cells from the lpr/lpr and +/+ donors were equivalently represented in the peripheral blood and thymus. In striking contrast, the T cells that accumulated in abnormally large numbers in the lymph nodes were almost entirely from the lpr donor. Their surface phenotype was Thy-1+(dull), Ly-1.2+(dull), Lyt-2-, L3T4-, 9F3+, and 3A1+, which is consistent with that found in intact lpr mice. These results indicate that the lpr gene causes an intrinsic defect directly within the T cells that accumulate in large numbers in lpr mice. In addition, the presence of the +/+ T cells cannot prevent the expression of the lpr abnormalities.

Citing Articles

Targeting apoptosis in cancer therapy.

Carneiro B, El-Deiry W Nat Rev Clin Oncol. 2020; 17(7):395-417.

PMID: 32203277 PMC: 8211386. DOI: 10.1038/s41571-020-0341-y.


Dysregulation of T Follicular Helper Cells in Lupus.

Mountz J, Hsu H, Ballesteros-Tato A J Immunol. 2019; 202(6):1649-1658.

PMID: 30833421 PMC: 6402788. DOI: 10.4049/jimmunol.1801150.


Remarkably Robust Antiviral Immune Response despite Combined Deficiency in Caspase-8 and RIPK3.

Feng Y, Livingston-Rosanoff D, Roback L, Sundararajan A, Speck S, Mocarski E J Immunol. 2018; 201(8):2244-2255.

PMID: 30194111 PMC: 6211196. DOI: 10.4049/jimmunol.1800110.


Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity.

Wilhelm A, Zabalawi M, Grayson J, Weant A, Major A, Owen J Arterioscler Thromb Vasc Biol. 2009; 29(6):843-9.

PMID: 19286630 PMC: 2761013. DOI: 10.1161/ATVBAHA.108.183442.


Fas expression on antigen-specific T cells has costimulatory, helper, and down-regulatory functions in vivo for cytotoxic T cell responses but not for T cell-dependent B cell responses.

Puliaeva I, Puliaev R, Shustov A, Haas M, Via C J Immunol. 2008; 181(9):5912-29.

PMID: 18941180 PMC: 2775525. DOI: 10.4049/jimmunol.181.9.5912.


References
1.
Steinberg A, Roths J, MURPHY E, Steinberg R, Raveche E . Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J Immunol. 1980; 125(2):871-3. View

2.
Mountz J, MUSHINSKI J, Mark G, Steinberg A . Oncogene expression in autoimmune mice. J Mol Cell Immunol. 1985; 2(3):121-31. View

3.
Lewis D, Giorgi J, Warner N . Flow cytometry analysis of T cells and continuous T-cell lines from autoimmune MRL/l mice. Nature. 1981; 289(5795):298-300. DOI: 10.1038/289298a0. View

4.
Glasebrook A, Sarmiento M, Loken M, Dialynas D, Quintans J, EISENBERG L . Murine T lymphocyte clones with distinct immunological functions. Immunol Rev. 1981; 54:225-66. DOI: 10.1111/j.1600-065x.1981.tb00439.x. View

5.
Theofilopoulos A, Balderas R, Shawler D, Lee S, Dixon F . Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice. J Exp Med. 1981; 153(6):1405-14. PMC: 2186176. DOI: 10.1084/jem.153.6.1405. View